U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Propofol Injectable Emulsion
Status: Currently in Shortage
»Date first posted: 04/10/2020
»Therapeutic Categories: Anesthesia

Expand all

Dr. Reddy's Laboratories, Inc. (Reverified 07/19/2022)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg/20mL 10ct (NDC 43598-265-58) Pack size discontinued
200mg/20mL vial, individual (NDC 43598-265-20) No current supply

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug. Manufacturer extended lead times.
500mg/50mL 20ct (NDC 43598-548-21) Allocating to Wholesalers Demand increase for the drug. Manufacturer extended lead times.
500mg/50mL vial, individual (NDC 43598-548-50) Allocating to Wholesalers

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug. Manufacturer extended lead times.
1000mg/100mL vial, 10ct (NDC 43598-549-10) Allocating to Wholesalers Demand increase for the drug. Manufacturer extended lead times.
1000mg/100mL vial, individual (NDC 43598-549-52) Allocating to Wholesalers

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug. Manufacturer extended lead times.
200mg/20mL vial, 25ct (NDC 43598-265-25) No current supply Demand increase for the drug. Manufacturer extended lead times.

Fresenius Kabi USA, LLC (Reverified 08/12/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10) Available
200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29) Available Demand increase for the drug
500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50) Available Demand increase for the drug
1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65) Available Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 04/08/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL vial (NDC 0641-6194-10) This presentation is temporarily on backorder. Recovery is TBD at this time. Demand increase for the drug
10 mg/mL, 50 mL vial (NDC 0641-6195-20 This presentation is temporarily on backorder. Recovery is TBD at this time. Demand increase for the drug
10 mg/mL, 100 mL vial (NDC 0641-6196-10 This presentation is temporarily on backorder. Recovery is TBD at this time. Demand increase for the drug

Hospira, Inc. (Revised 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/20 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0209-10) Limited Supply Available. Next Delivery and Estimated Recovery: June 2022 Demand increase for the drug
500 mg/50 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0234-20) Available Other
1000 mg/100 mL (10 mg/mL) Single Use Vial (containing 0.005% edetate disodium EDTA) (NDC 00069-0248-10) Available
200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30) Available Other
500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33) Limited Supply Available. Next Delivery and Estimated Recovery: July 2022 Demand increase for the drug
1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24) Limited Supply Available. Next Delivery and Estimated Recovery: June 2022 Demand increase for the drug

Sagent Pharmaceuticals (Reverified 08/12/2022)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg per 20ml (NDC 25021-608-20) Available Demand increase due to Covid-19
500mg per 50ml (NDC 250-21-608-50) Available
1000mg per 100ml (NDC 25021-608-51) Available

Teva Pharmaceuticals (Revised 07/01/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10MG/ML 10X100ML VL (NDC 0591-2136-68) Backordered - Market Exit Estimated July 2022

Link to Discontinuance


Link to FDA's List of Extended Use Dates
Discontinuance of Manufacturing
10MG/ML 20X50ML VL (NDC 0591-2136-51) Market Exit. Estimated run out June/July 2022

Link to Discontinuance


Link to FDA's List of Extended Use Dates
Discontinuance of Manufacturing
10MG/ML 25X20ML VL (NDC 0591-2136-95) Market Exit. Estimated run out April/May 2023

Link to Discontinuance


Link to FDA's List of Extended Use Dates
Discontinuance of Manufacturing
Back to Top